RamSoft announced it will be introducing an industry first medical imaging patient app, Blume powered by ChatGPT – at HIMSS 2023 in Chicago

April 14, 2023 — RamSoft announced it will be introducing an industry first medical imaging patient app, Blume powered by ChatGPT – at HIMSS 2023 in Chicago.  

This new feature, driven by the AI chatbot technology of ChatGPT, allows patients to ask questions and receive quick, plain-language answers about medical imaging procedures such as MRIs, Ultrasound exams, PET/CT scans etc. This feature is expected to improve patient satisfaction and outcomes by ensuring patients are better informed about the care they are being provided.  

According to Vijay Ramanathan, RamSoft CEO, “Two key factors underline the importance of addressing patient centricity. First, leveraging the widespread adoption of smartphones to enhance doctor-patient communication and second, complying with the 21st Century Cures Act which mandates that healthcare providers share images and reports with patients”.  

Blume: More Than a Patient Portal  

Blume empowers patients to navigate their entire healthcare journey from their smartphone. With its highly intuitive user interface, patients can easily and efficiently perform a broad range of activities including:  

  • Remote completion and submission of intake forms  
  • Self-scheduling and managing appointment requests  
  • Check insurance eligibility  
  • Securely share medical images and reports with doctors, family, or friends  

Blume is available for both Android and iOS devices and can be downloaded via Google Play and Apple’s App Store.  

RamSoft will be showcasing Blume with its new AI feature powered by ChatGPT, in conjunction with OmegaAI at HIMSS23. Event attendees may reserve an exclusive preview at RamSoft booth 3614. For those not attending, reserve your personal online demo. 

For more information: www.ramsoft.com 


Find more HIMSS23 coverage here 


Related Content

News | Radiation Oncology

May 10, 2024 — Mariana Oncology, a fully integrated biotechnology company pioneering a new era of radiopharmaceutical ...

Time May 10, 2024
arrow
News | ARRS

May 8, 2024 — Compared to males, women in radiology are at a consistently higher risk of not matching into diagnostic ...

Time May 08, 2024
arrow
News | Contrast Media

May 8, 2024 — Swedish biotech company Ascelia Pharma AB has announced that its liver imaging drug candidate, Orviglance ...

Time May 08, 2024
arrow
News | ARRS

May 7, 2024 — The American Roentgen Ray Society (ARRS) announced that Philip Costello, MD, the 118th ARRS President and ...

Time May 07, 2024
arrow
News | Mammography

May 6, 2024 — Enable Me, a VELA Medical company, cited major new research by Siemens Healthineers entitled, “The future ...

Time May 06, 2024
arrow
Feature | Digital Radiography (DR) | By Melinda Taschetta-Millane

Digital radiography (DR) continues to advance at a rapid pace with today’s technological innovations and evolving ...

Time May 06, 2024
arrow
Feature | Radiology Business | By Melinda Taschetta-Millane

One on One interviews with radiology trailblazers and historic FDA clearances made the top-read list for April. Take a ...

Time May 03, 2024
arrow
Feature | Radiology Business | By William T. Thorwarth Jr., MD, FACR

As we witness a mounting backlash against prior authorization in healthcare, we must explore more effective alternatives ...

Time May 02, 2024
arrow
News | Breast Imaging

May 1, 2024 — Hologic, Inc., a global leader in women’s health, today announced that it signed a definitive agreement to ...

Time May 01, 2024
arrow
News | Breast Imaging

May 1, 2024 — After the issuance of updated breast screening recommendations by the U.S. Preventive Services Task Force ...

Time May 01, 2024
arrow
Subscribe Now